Peringatan Keamanan

Oral LD50 in the rat is 3000 mg/kg L2476

Adverse effects can be divided into several categories L2464, L2475:

Eyes: irritation L2475

Skin: skin irritation L2475

Cardiovascular: rapid pulse, flushing L2464

Central Nervous System —blurred vision, dizziness L2464

Respiratory —shortness of breath or troubled breathing L2464, irritation of respiratory system L2475

Genitourinary —difficult micturition, acute urinary retention L2464

Gastrointestinal —dry mouth, nausea/vomiting L2464

Overdosage may be managed by inducing emesis or gastric lavage. Slow intravenous administration of physostigmine in doses of 1 to 4 mg (0.5 to 1 mg in children) repeated as needed in 1-2 h to relieve severe antimuscarinic symptoms. Administration of small doses of diazepam to control excitement and seizures may be warranted. Artificial respiration with oxygen can be used if needed for respiratory depression. Adequate hydration is important, as well as symptomatic treatment, provided as necessary L2464.

Phenyl salicylate

DB11071

small molecule approved

Deskripsi

Phenyl salicylate is a 2-hydroxybenzoic acid phenyl ester. It is utilized in some manufacturing processes of polymers, lacquers, adhesives, waxes, as well as polishes. It is an active ingredient in some pharmaceutical products as a mild analgesic for pain relief by releasing salicylate (found in DB00945 ). Phenyl salicylate may also be found in some antiseptic agents L2467. It is synthesized by heating salicylic acid with phenol L2468, MSDS.

Phenyl salicylate is used as a food additive in the USA L2479.

This compound belongs to the class of organic compounds known as depsides and depsidones. These are polycyclic compounds that is either a polyphenolic compound composed of two or more monocyclic aromatic units linked by an ester bond (depside), or a compound containing the depsidone structure (depsidone) L2477.

Struktur Molekul 2D

Berat 214.2167
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) Mean half-life of 1.1 h [L2478].
Volume Distribusi Steady-state plasma salicylate concentrations increase more than proportionally with increasing dosages; the time required to reach steady state increases with increasing daily dose. Dosage intervals of 8-12 h are sufficient to maintain plasma salicylate concentrations in the normal therapeutic anti-inflammatory concentration range [L2473].
Klirens (Clearance) Please refer to [DB00945] for more information.

Absorpsi

Rapidly absorbed. Refer to DB00945 for detailed salicylate absorption information.

Metabolisme

Hydrolyzed to salicylic acid L2474. Salicylic acid elimination kinetics are dependent on drug concentration because of the limited capacity of two major biotransformation pathways: formation of salicyluric acid and of salicyl phenolic glucuronide. Metabolism of this drug occurs mainly in the liver, like other salicylates A32453. Metabolism of salicylic acid occurs through glucuronide formation (to produce salicyluric acid), and salicyl phenolic glucuronide), conjugation with glycine (to produce salicyluric acid), and oxidation to form gentisic acid. The rate of formation of salicyl phenolic glucuronide and salicyluric acid are easily saturated at low salicylic acid concentrations and their formation can be described by Michaelis-Menten kinetics A32453.

Rute Eliminasi

Please refer to DB00945 for the route of elimination.

Interaksi Obat

0 Data
Tidak ada data.

Target Protein

Prostaglandin G/H synthase 1 PTGS1
Prostaglandin G/H synthase 2 PTGS2

Referensi & Sumber

Artikel (PubMed)
  • PMID: 14592543
    Vane JR, Botting RM: The mechanism of action of aspirin. Thromb Res. 2003 Jun 15;110(5-6):255-8.
  • PMID: 26321725
    Ozaki H, Sugihara K, Tamura Y, Fujino C, Watanabe Y, Uramaru N, Sone T, Ohta S, Kitamura S: Hydrolytic metabolism of phenyl and benzyl salicylates, fragrances and flavoring agents in foods, by microsomes of rat and human tissues. Food Chem Toxicol. 2015 Dec;86:116-23. doi: 10.1016/j.fct.2015.08.024. Epub 2015 Aug 28.
  • PMID: 3888490
    Needs CJ, Brooks PM: Clinical pharmacokinetics of the salicylates. Clin Pharmacokinet. 1985 Mar-Apr;10(2):164-77. doi: 10.2165/00003088-198510020-00004.

Contoh Produk & Brand

Produk: 44 • International brands: 0
Produk
  • Azuphen Mb
    Capsule • - • Oral • US
  • Darcalma
    Tablet • - • Oral • US
  • Darcalma
    Tablet • - • Oral • US
  • Darpaz
    Tablet • - • Oral • US
  • Hyolev Mb
    Tablet • - • Oral • US
  • Hyophen
    Tablet • - • Oral • US
  • Hyophen
    Tablet • - • Oral • US
  • Methylphen
    Tablet • - • Oral • US
Menampilkan 8 dari 44 produk.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul